Anthrax toxins have attracted considerable attention as potential anticancer agents due to their ability to specifically target and kill tumor cells. However, the clinical development of these toxins has been limited because the mechanisms underlying their antitumor effects have been unclear, and because their long-term use is precluded by the body’s strong immune response against these foreign proteins.
Researchers examined the antitumor effects of anthrax toxins, and found that combined treatment with immunosuppressive drugs enables multiple cycles of therapy and reduction in tumor growth.
Using genetic mouse models, the authors found that anthrax toxins reduce tumor growth by binding to capillary morphogenesis protein-2 on tumor endothelial cells, thereby inhibiting the formation of new blood vessels.
Moreover, the antitumor effects of anthrax toxins in mice with an aggressive form of lung cancer were enhanced by combined treatment with immunosuppressants called pentostatin and cyclophosphamide. These two clinically approved drugs selectively depleted B-cell populations and eliminated toxin-neutralizing antibodies, enabling five cycles of therapy over the course of 42 days.
According to the authors, combined treatment with anthrax toxins and immunosuppressive drugs could lead to strong, long-term reductions in tumor growth and may warrant further investigation in clinical trials for a broad spectrum of cancers.
http://www.pnas.org/content/early/2016/06/28/1600982113
Anthrax toxin therapy for cancer
- 2,030 views
- Added
Edited
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
Spicy molecule inhibits growth of breast cancer cells
Read more
Tumor cells move differently than normal ones
Read more
Role of fat utilization (beta-oxidation) in cancer spread!
Cancer cells spread to other sites in the body through promoting the growth of new 'roads' to travel on. In a study to be published in the top scientific journal, Nature, an international and multidisciplinary team of researchers, discovered how a shift to increased fat utilization is required for the development and growth of these 'roads', termed lymphatic vessels - a special kind of blood vessels…
Read more
Personalizing cancer treatment- patients sensitive to new type of c…
Read more
Naturally occurring mechanism of cancer drug-resistance may itself…
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar